COM:REGENERON
Regeneron Pharmaceuticals, Inc.
- Stock
locale
United States
market
STOCKSindustry
Pharmaceuticalswebsite
regeneron.comcrunchbase
regeneron-pharmaceuticalslinkedin
regeneron-pharmaceuticalsfounding date
Jan 01, 1988ipo date
Apr 02, 1991
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein oc...Show More